newsfilter
← Latest News
PR Newswire·

Seneca Biopharma Announces Closing of Exercise of Warrants for $7.55 Million Gross Proceeds

Seneca Biopharma, Inc. (Nasdaq: SNCA), a clinical-stage biopharmaceutical company developing novel treatments for various diseases of high unmet...